Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Melanoma

  Free Subscription


12.10.2026

1 Br J Cancer
2 Br J Dermatol
1 J Am Acad Dermatol
1 J Clin Oncol
1 Melanoma Res
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Br J Cancer

  1. KARAKULAK T, Moch H, von Mering C, Kahraman A, et al
    Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemia.
    Br J Cancer. 2026 Oct 3. doi: 10.1038/s41416-026-03638.
    PubMed         Abstract available


    Br J Dermatol

  2. RAMAMURTHY SRINIVASAN M, de Berker D, Venables ZC, Levell NJ, et al
    The environmental burden of melanoma: a national stage-specific carbon footprint analysis.
    Br J Dermatol. 2026 Oct 8:ljag440. doi: 10.1093.
    PubMed        

  3. ADALSTEINSSON JA, Karadottir HL
    Surviving stage IV melanoma: the unfinished task of survivorship care.
    Br J Dermatol. 2026 Oct 5:ljag438. doi: 10.1093.
    PubMed        


    J Am Acad Dermatol

  4. GONZALEZ-CAO M, Puig S, Manzano JL, Berciano-Guerrero MA, et al
    Primary Melanoma Stage as a Predictor of Survival in Advanced Disease: Findings from the Spanish Melanoma Registry GEM1801.
    J Am Acad Dermatol. 2026 Oct 5:S0190-9622(26)03663.
    PubMed         Abstract available


    J Clin Oncol

  5. HURD D, Davar D
    Reading Melanoma's Differentiation State to Settle the Combination Versus Sequencing Debate.
    J Clin Oncol. 2026 Oct 8:JCO2601593. doi: 10.1200/JCO-26-01593.
    PubMed        


    Melanoma Res

  6. JIANG C, Niu S, Li C, Liu A, et al
    Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.
    Melanoma Res. 2026 Oct 6. doi: 10.1097/CMR.0000000000001143.
    PubMed         Abstract available


    PLoS One

  7. LEI X, Liu W, Luo Z, Wu B, et al
    CD3-CSPG4 bispecific T cell engager: A novel platform for malignant melanoma therapy.
    PLoS One. 2026;21:e0357790.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum